1,390
Views
4
CrossRef citations to date
0
Altmetric
Editorial

The changing landscape in drug resistant-tuberculosis: an analysis of recent advances

, , &
Pages 603-606 | Received 19 Jan 2016, Accepted 07 Mar 2016, Published online: 28 Mar 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Ignacio Monedero, Rajita Bhavaraju, Alberto Mendoza-Ticona & Adrián Sánchez-Montalvá. (2017) The paradigm shift to end tuberculosis. Are we ready to assume the changes?. Expert Review of Respiratory Medicine 11:7, pages 565-579.
Read now

Articles from other publishers (3)

Adrián Sánchez-Montalvá, Marta Barios, Fernando Salvador, Ana Villar, Teresa Tórtola, Daniel Molina-Morant, Carles Lorenzo-Bosquet, Juan Espinosa-Pereiro & Israel Molina. (2019) Usefulness of FDG PET/CT in the management of tuberculosis. PLOS ONE 14:8, pages e0221516.
Crossref
Ting-Yen Wei, Yun Fu, Kuo-Hsuan Chang, Kun-Ju Lin, Yu-Jen Lu & Chao-Min Cheng. (2018) Point-of-Care Devices Using Disease Biomarkers To Diagnose Neurodegenerative Disorders. Trends in Biotechnology 36:3, pages 290-303.
Crossref
Jeong Ha Mok, Bo Hyoung Kang, Taehoon Lee, Hyun-Kyung Lee, Hang Jea Jang, Yu Ji Cho & Doosoo Jeon. (2017) Additional Drug Resistance Patterns among Multidrug-Resistant Tuberculosis Patients in Korea: Implications for Regimen Design. Journal of Korean Medical Science 32:4, pages 636.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.